Industry Insights
[195+ Pages Report] According to the report published by Facts & Factors, the global atopic eczema treatment market was estimated at approximately USD 18,057.4 Million in 2019 and is anticipated to generate revenue of around USD 34,089.3 Million by end of 2026, growing at a CAGR of around 10.36% between 2020 and 2026.
Global Atopic Eczema Treatment Market: Overview
Eczema (atopic dermatitis) is a skin disease that causes itchiness on the skin and making the skin surface look dry and red. It's more common in kids, but it can strike someone at any age. Atopic dermatitis is a long-term (chronic) condition that flares up from time to time. There is yet no treatment for atopic eczema, but doctors suggest self-care treatments helping to ease itching and deter new outbreaks. Some treatments that are considered to be beneficial are avoiding any usage of harsh soaps, moisturizing the skin regularly, and applying medicated creams or ointments.
Global Atopic Eczema Treatment Market: Growth Factors
The atopic eczema treatment industry has gained momentum in recent years as people have become more knowledgeable of the disease's care options. Government initiatives to offer quality and more affordable care, as well as the presence of attractive payment plans, is expected to give the industry a boost. One of the big roadblocks in the market's upward climb is the high cost of therapeutics. Affordable healthcare policies, on the other hand, are being implemented in all main countries, affecting company price plans as well as payment possibilities. Nevertheless, there are multiple opportunities where a permanent cure for the disease could be developed by the key players or else can develop a systematic treatment to recover affected patients from atopic eczema infections.
Global Atopic Eczema Treatment Market: Segmentation
Based on the type segment, the atopic eczema treatment market is divided into topical, oral, and injectable, out of which, the topical type holds the maximum market share as they are widely prescribed and used drugs in atopic eczema treatments. They are generally using in combination with moisturizers or emollients as they give more effective results in this way. These topical creams can be easily applied and washed from the skin. These topical moisturizers are anti-inflammatory helping to lower skin itching and rash, thus helping to lock in the water and avoid more dryness. On the basis of application, the market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, and others. The segment of online pharmacies holds the largest share as compared with other segments as it gives access to eczema treatment medicines with various brands to choose from with varying prices. Online pharmacies are also helpful for those who have a busy lifestyle and do not have time to visit a local pharmacy or else for the people who live a long way from their nearest pharmacy. The elderly people who are unable to travel independently also prefer ordering their medicines from online pharmacies. Online pharmacies also helped in delivering medicines to the patients who were under lockdown and were unable to get their medicines from the local pharmacy store. It also helped in delivering the medicines on time as COVID-19 had an impact on the delivery duration of medicines in the local pharmacies.
Global Atopic Eczema Treatment Market: Regional Analysis
The region of North America is anticipated to dominate the atopic eczema treatment market over the forecasted period owing to well-developed technologies, an increase in patients with poor protein filaggrin levels, an increase in the incidence of atopic disease, high healthcare expenditures, and increased government funding for R&D. Furthermore, the demand in this area has grown owing to increased R&D activities and the presence of major companies in the region. Owing to the surging government funding for research and development and the availability of funds for research, Europe ranks second in the global atopic eczema treatment industry. Over the forecasted timeframe, this is likely to continue to drive the European economy. Countries such as Germany and France, for example, are growing their investments in healthcare. Due to rapidly evolving healthcare technologies, a large patient population, and high healthcare spending, Asia Pacific is the fastest growing atopic eczema treatment market. Furthermore, developing demand for new treatment approaches in countries such as India and South Korea is projected to emerge as the world's fastest-growing market. Furthermore, the demand for high-quality medical products is expected to lead to an increased usage of advanced equipment, which will boost atopic eczema treatment market growth in the area.
Global Atopic Eczema Treatment Market: Competitive Players
The major players dominating the global atopic eczema treatment market in terms of revenue and development are Encore Dermatology Inc., AbbieVie Inc., F. Hoffmann-La Roche AG, Novartis AG, GlaxoSmithKline plc.,Regeneron Pharmaceuticals Inc., Medimmune LLC. (AstraZeneca), LEO Pharma A/S, Sanofi S.A, Valeant Pharmaceuticals Inc., Pfizer Inc., and Others. To achieve a reputable foothold in the global economy, these big players have used a range of tactics, including signing deals, shares, leases, alliances, joint ventures, new product releases, collaborations, and mergers and acquisitions. These big companies have used a number of techniques to obtain a reputable spot in the global economy, including signing agreements, stakes, leases, partnerships, joint ventures, new product launches, collaborations, and mergers and acquisitions. For instance, in May 2016, Pfizer Inc. acquired Anacor Pharmaceuticals, Inc. for USD 99.25 per Anacor share. This acquisition would help Pfizer to a position where it would be able to address a major medical issue and develop medicine or find a cure for a major population suffering from mild-to-moderate atopic dermatitis, for which there are currently few safe topical remedies.
Atopic Eczema Treatment Market: Regional Segment Analysis
- North America
- U.S.
- Canada
- Europe
- U.K.
- France
- Germany
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- The Middle East and Africa
- GCC Countries
- South Africa
- Rest of MEA
KEY REPORT POINTERS & HIGHLIGHTS:
- Statistically Validated Analysis of Historical, Current, and Projected Industry Trends with Authenticated Market Sizes Information and Data in terms of Value and Volume, wherever applicable
- Direct and Indirect Factors that Impacted the Industry as well Projected Rationales expected to affect the industry going forward
- Micro, Meso, Macro, and In-Depth Analysis of Technically relevant and Commercially viable Segments and Sub-segments of the Market
- Historical and Projected Company / Vendor / OEM / Supplier Market Shares, Competitive Landscape, and Player Positioning Data
- Historical and Current Demand (Consumption) and Supply (Production) Scenarios as well as Projected Supply-Demand Scenario Analysis
- Detailed List of Key Buyers and End-Users (Consumers) analyzed as per Regions and Applications
- Value Chain and Supply Chain Analysis along with Horizontal and Vertical Integration Scenarios
- Manufacturing and Production Cost Structure Analysis including Labor Cost, Raw Material Expenses, and Other Manufacturing Expenses, wherever relevant
- Overview of Key Marketing Strategies and Key Sales Channels Adopted in the Market
- Market Attractiveness Analysis and Key Investment Opportunity Analysis in the Market going forward
- Technological Roadmap, Patents Analysis, Potential Substitutes, and Technical Analysis
- The professionally substantiated market research report study is calculated, constructed, and assembled by implementing a Robust Research Methodology. The Triangular Process comprises a buoyant mix of Exhaustive Primary Research (focused interviews, questionnaires, and ad-hoc surveys) and Extended Secondary Research (paid external databases, proprietary in-house database, and publically-available validated sources), where it is finally triangulated and validated through in-house industry experts, industry leaders, and independent consultants through a tri-level quality check practice.
Table of Content
Industry Major Market Players
- Encore Dermatology Inc.
- AbbieVie Inc.
- F. Hoffmann-La Roche AG
- Novartis AG
- Glaxosmithklineplc
- Regeneron Pharmaceuticals Inc.
- Medimmune LLC. (Astrazeneca)
- LEO Pharma A/S
- Sanofi S.A
- Valeant Pharmaceuticals Inc.
- Pfizer Inc
Safe and Secure SSL Encrypted
Choose License Type
COVID-19 Pandemic Impacts
Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.
BUY NOW or REQUEST SAMPLE to avail Detailed Analysis of the COVID-19 Impact on the Market
HAVE A QUESTION? Executive will help you find what you are looking for.
REQUEST CUSTOMIZATION
Still haven't found what you're looking for? Speak to our Custom Research Team
Learn More